ClinConnect ClinConnect Logo
Search / Trial NCT07039864

A Novel Strategy for Evaluating Gallbladder Contraction Function by Ultrasound

Launched by HEPATOPANCREATOBILIARY SURGERY INSTITUTE OF GANSU PROVINCE · Jun 18, 2025

Trial Information

Current as of June 28, 2025

Not yet recruiting

Keywords

Gallbladder Function Ultrasound Fatty Acids

ClinConnect Summary

This clinical trial is looking at a new way to check how well the gallbladder contracts, or squeezes, using ultrasound, a painless imaging technique. The study will test how certain fatty acids taken by mouth affect the gallbladder’s ability to contract. This is important because the gallbladder helps with digestion by releasing bile, and problems with its function can cause discomfort or digestive issues.

People who might be able to join this study are adults who have a normal gallbladder and bile duct structure, as confirmed by ultrasound. However, anyone with a history of gallbladder or bile duct surgery, certain digestive diseases, infections, or other serious health problems would not be eligible. The study has not started recruiting yet, and it will include both men and women. If you join, you can expect to undergo ultrasound scans and take the fatty acids being studied, so researchers can observe any changes in gallbladder function. This study aims to find better ways to understand and possibly improve gallbladder health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ultrasound assessment identifies people with normal biliary tract structure
  • Exclusion Criteria:
  • History of Endoscopic Retrograde Cholangiopancreatography
  • Previous gallstone removal surgery with gallbladder preservation
  • History of acute or chronic pancreatitis, cholangitis
  • Mirizzi Syndrome
  • History of gastrointestinal surgery
  • Gastrointestinal obstruction
  • Dysfunction of the sphincter of Oddi
  • Gallbladder neck polyps
  • Abnormal gallbladder structure
  • Gallbladder mass
  • Biliary infection or stones
  • Congenital biliary abnormalities
  • Biliary injury or surgery
  • Biliary tumors
  • Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
  • Significant arrhythmia, bradycardia, or atrioventricular block
  • Severe hypertension, liver or kidney insufficiency
  • Immune, endocrine, hematological, or mental disorders
  • Severe cerebrovascular disease
  • Allergy to relevant foods
  • Pregnant or breastfeeding women
  • Unwillingness or inability to consent to participation

About Hepatopancreatobiliary Surgery Institute Of Gansu Province

The Hepatopancreatobiliary Surgery Institute of Gansu Province is a leading clinical research organization dedicated to advancing the field of hepatopancreatobiliary surgery through innovative research and high-quality patient care. Located in Gansu Province, China, the institute specializes in the diagnosis, treatment, and surgical management of liver, pancreas, and biliary disorders, with a commitment to improving patient outcomes and enhancing surgical techniques. By conducting rigorous clinical trials, the institute aims to contribute to the global body of knowledge in surgical practices and therapies, fostering collaboration with healthcare professionals and institutions worldwide.

Locations

Lanzhou, Gansu, China

Patients applied

0 patients applied

Trial Officials

Wenbo Meng, M.D. Ph. D.

Principal Investigator

Hepatopancreatobiliary Surgery Institute of Gansu Province

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported